Official UK procurement notice
NP47926 Biologic, Biosimilar’s and Methotrexate Injections
Authority: The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
What is being bought13 lots · detail below
Published requirement descriptionSupply of Biologics, Biosimilars and Methotrexate Injections to NHS Scotland.
CPV: Antineoplastic and immunomodulating agents · General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents · Pharmaceutical products · Various medicinal products
How this framework works
From the published notice- Places
- up to 18 suppliers
Lots and requirements (13)Procurement structure
13 lots · 12 with a published value · same evaluation weights on every lotLot #1AdalimumabRenewalPublished value£68,840,541
Supply of adalimumab to NHS Scotland.
The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 7 Framework Participants.
Full details of Goods and volumes can be found within the ITT documents.
Lot #2EtanerceptRenewalPublished value£56,785,379
Supply of etanercept to NHS Scotland.
The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 5 Framework Participants.
Full details of Goods and volumes can be found within the ITT documents.
Lot #3GolimumabRenewalPublished value£17,468,277
Supply of golimumab to NHS Scotland.
The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 4 Framework Participants.
Full details of Goods and volumes can be found within the ITT documents.
Lot #4Infliximab Intravenous InfusionRenewalPublished value£30,991,783
Supply of infliximab intravenous infusion to NHS Scotland.
The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 6 Framework Participants.
Full details of Goods and volumes can be found within the ITT documents.
Lot #5Infliximab Subcutaneous InjectionRenewalPublished value£18,830,820
Supply of infliximab subcutaneous injection to NHS Scotland.
The Authority intends to award this Lot as a single supplier framework per product line.
Full details of Goods and volumes can be found within the ITT documents.
Lot #6Methotrexate (50mg/1ml concentration) Pre-Filled Self Injection DeviceRenewalPublished value£3,719,554
Supply of Methotrexate (50mg/1ml concentration) Pre-Filled Self Injection Device to NHS Scotland.
The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants.
Full details of Goods and volumes can be found within the ITT documents.
Lot #7Methotrexate (50mg/1ml concentration) Pre-Filled SyringeRenewalPublished value£2,071
Supply of Methotrexate (50mg/1ml concentration) Pre-Filled Syringe to NHS Scotland.
The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants.
Full details of Goods and volumes can be found within the ITT documents.
Lot #8Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection DeviceRenewalLot estimate not published
Supply of Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Device to NHS Scotland.
The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants.
Full details of Goods and volumes can be found within the ITT documents.
Lot #9Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection SyringeRenewalPublished value£14,565
Supply of Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Syringe to NHS Scotland.
The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 3 Framework Participants.
Full details of Goods and volumes can be found within the ITT documents.
Lot #10OmalizumabRenewalPublished value£18,669,166
Supply of omalizumab to NHS Scotland.
The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 4 Framework Participants.
Full details of Goods and volumes can be found within the ITT documents.
Lot #11TildrakizumabRenewalPublished value£4,231,882
Supply of tildrakizumab to NHS Scotland.
The Authority intends to award this Lot as a single supplier framework per product line.
Full details of Goods and volumes can be found within the ITT documents.
Lot #12TocilizumabRenewalPublished value£46,446,380
Supply of tocilizumab to NHS Scotland.
The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 5 Framework Participants.
Full details of Goods and volumes can be found within the ITT documents.
Lot #13UstekinumabRenewalPublished value£68,865,598
Supply of ustekinumab to NHS Scotland.
The Authority intends to award this Lot as an unranked multi-supplier framework per product line to a maximum of 9 Framework Participants.
Full details of Goods and volumes can be found within the ITT documents.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (2)
- API Sources: 5%
- price: 95%
Published award criteria (2)
- API Sources: 5
- Price: 95
- Suitability
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015
- Technical & professional ability
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the start date.
(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
(c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging.
(d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.
Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the start date should be included in the Qualification Envelope of the ITT under the …
- Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
- “NP47926 Biologic, Biosimilar’s and Methotrexate Injections” is a framework: the contest is a place on its panel, up to 18 suppliers, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Closed
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 21 Sept 2026, 10:11 BST
- Last source update
- 21 Sept 2026, 10:11 BST
- Award evaluation window
- 21 Oct 2026 – …
- FTS notice number
2026/S 000-088983- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-077614Find a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.
Publisher note: The estimated value(s) referred to in Section II.1.5 and within all Lots cover(s) the 24 month contract duration and the 24 month extension period of the framework agreement. The buyer is using PCS-Tender to conduct this ITT exercise. The Project code is 32662. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2343 A sub-contract clause has been included in this contract. For more information see: http://www.publiccontractsscotland.gov.uk/info/InfoCentre.aspx?ID=2363 Community benefits are included in this requirement. For more information see: https://www.gov.scot/policies/public-sector-procurement/community-benefits-in-procurement/ A summary of the expected community benefits has been provided as follows: It is a mandatory requirement that potential framework participants agree to support the concept, provision, and ongoing development of community benefits provision in relation to this framework. Potential framework participants are required to agree to this mandatory requirement. They are also requested to provide a summary of the community benefits that have recently been delivered within Scotland, if at all, and what impact and outcomes these have achieved. Potential framework participants are required to summarise any proposed community benefits that will be developed and delivered as part of this framework if successful or, alternatively, potential framework participants confirm that they will engage with the NHS Scotland’s Community Benefits Gateway (CBG). This gateway, developed through requests from suppliers seeking opportunities to support the delivery of community benefits within the contracting region, provides information on community benefit opportunities. The CBG is a free and easy to use online service that connects NHS Scotland suppliers with third sector community organisations within Scotland and will be used for tracking and reporting and is an approved compliant route to the realisation of community benefits. For further information please visit NHSS Community Benefit Gateway (https://www.nss.nhs.scot/procurement-and-logistics/sustainability/access-our-community-benefit-gateway/). (SC Ref:841676)
How it was run
Official notice- Appointment period ends
- 21 Oct 2026, 12:00 BST
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bids opened
- 21 Oct 2026, 12:00 BST
Timeline
21 Sept 2026 → 21 Oct 2026 · 3 dates- Notice published36 days ago21 Sept 2026, 10:11 BST
- Admission / appointment period ends6 days ago · period end, not a bid countdown21 Oct 2026, 12:00 BST
- Bids opened6 days ago21 Oct 2026, 12:00 BST
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Sheriff Court HouseReview body
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.